The Association between ABCB1 C1236T/C3435T SNPs and H. pylori Infection among Jordanians

Infection with Helicobacter pylori (H. pylori) is very common and affecting about 50% of the worldwide population. Several genetic variations have been implicated in determining the clinical susceptibility to this infection. In the current study, we examined the association between C1236T (rs1045642) and C3435T (rs1045642) single nucleotide polymorphisms (SNPs) in the ABCB1 gene and the prevalence of H. pylori infection among Jordanians. A total of 412 subjects (257 H. pylori-positive cases and 155 H. pylori-negative controls) were recruited and participated in the study, and the genotyping of the ABCB1 gene was performed using RFLP-PCR techniques. A significant association was detected between C1236T and H. pylori infection (p < 0.01). The frequency of CT genotype was significantly higher in the positive cases (40.1%) compared to the controls (21.3%). In addition, the C3435T SNP was weakly associated with H. pylori infection (p = 0.077). Haplotype analysis of C1236T and C3435T SNPs showed that the TT haplotype was present in 22.7% of the positive cases compared to 30.7% of the negative controls (p < 0.05, odds ratio = 0.663, 95% CI: (0.483–0.911)). Consequently, the TT haplotype seems to decrease the risk of H. pylori infection. In conclusion, the current results suggest an association between ABCB1 SNPs and H. pylori infection in the Jordanian population.

[1]  Hells Mesa Tuff Previous , 2020, Definitions.

[2]  T. Kanai,et al.  Previous Helicobacter pylori infection–induced atrophic gastritis: A distinct disease entity in an understudied population without a history of eradication , 2019, Helicobacter.

[3]  F. F. de Melo,et al.  Pathogenesis and clinical management of Helicobacter pylori gastric infection , 2019, World journal of gastroenterology.

[4]  I. Mitov,et al.  Multidrug resistance in Helicobacter pylori: current state and future directions , 2019, Expert review of clinical pharmacology.

[5]  F. Pourfarzi,et al.  Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives , 2019, Cancer medicine.

[6]  M. Curado,et al.  Prevalence of Helicobacter pylori infection in Latin America and the Caribbean populations: A systematic review and meta-analysis. , 2019, Cancer epidemiology.

[7]  Y. Yamaoka,et al.  Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam , 2019, Gut and liver.

[8]  I. Maev,et al.  [Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy]. , 2017, Terapevticheskii arkhiv.

[9]  D. Scott,et al.  The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors , 2017, Current Gastroenterology Reports.

[10]  R. Malekzadeh,et al.  Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran , 2017, Digestive Diseases and Sciences.

[11]  Jun Chen,et al.  Influence of TS and ABCB1 gene polymorphisms on survival outcomes of 5‑FU-based chemotherapy in a Chinese population of advanced gastric cancer patients , 2017, Wiener klinische Wochenschrift.

[12]  Manfred Uhr,et al.  ABCB1 genotyping in the treatment of depression. , 2016, Pharmacogenomics.

[13]  J. Ford,et al.  Genetic predisposition to gastric cancer. , 2016, Seminars in oncology.

[14]  Jianhua Lin,et al.  Etiology and Prevention of Gastric Cancer , 2016, Gastrointestinal Tumors.

[15]  T. Cover Helicobacter pylori Diversity and Gastric Cancer Risk , 2016, mBio.

[16]  Wentao Liu,et al.  New blood markers detection technology: A leap in the diagnosis of gastric cancer. , 2016, World journal of gastroenterology.

[17]  R. Vilaichone,et al.  Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[18]  H. Saito,et al.  First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype. , 2015, World journal of gastroenterology.

[19]  H. Lerche,et al.  Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature , 2015, Clinical Pharmacokinetics.

[20]  L. Shen,et al.  [Association between ABCB1 G2677T/A polymorphisms and chemosensitivity of paclitaxel in advanced gastric cancer]. , 2015, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.

[21]  D. Jesionek-Kupnicka,et al.  Is the ABCB1 gene associated with the increased risk of gastric cancer development?--preliminary research. , 2014, Pathology, research and practice.

[22]  Deng-Chyang Wu,et al.  CYP2C19 polymorphism influences Helicobacter pylori eradication. , 2014, World journal of gastroenterology.

[23]  M. Al-Jarrah,et al.  Association of adiponectin protein and ADIPOQ gene variants with lumbar disc degeneration , 2014, Experimental and therapeutic medicine.

[24]  ZhouXiaojun,et al.  Association Between the c.3073A>C Genetic Polymorphism of the MDR1 Gene and Susceptibility to Gastric Cancer in the Chinese Han Population , 2014 .

[25]  N. Mhaidat,et al.  The role of Multidrug Resistance-1 (MDR1) variants in response to atorvastatin among Jordanians , 2015, Cytotechnology.

[26]  A. Brambila-Tapia MDR1 (ABCB1) polymorphisms: functional effects and clinical implications. , 2013, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[27]  N. Mhaidat,et al.  The effect of genetic polymorphisms of RARA gene on the adverse effects profile of isotretinoin-treated acne patients. , 2013, International journal of clinical pharmacology and therapeutics.

[28]  Li Zhang,et al.  Association between single genetic polymorphisms of MDR1 gene and gastric cancer susceptibility in Chinese , 2013, Medical Oncology.

[29]  S. Staibano,et al.  MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells , 2012, Laboratory Investigation.

[30]  R. Parsons,et al.  P‐glycoprotein expression in Helicobacter pylori‐positive patients: The influence of MDR1 C3435T polymorphism , 2012, Journal of digestive diseases.

[31]  N. Forones,et al.  Association between the C3435T single-nucleotide polymorphism of multidrug resistance 1 gene and risk of gastric cancer. , 2012, Molecular medicine reports.

[32]  Y. Li,et al.  MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[33]  J. Behravan,et al.  Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population. , 2010, Indian journal of cancer.

[34]  T. Tahara,et al.  Promoter Methylation Status of Multidrug Resistance 1 (MDR1) Gene in Noncancerous Gastric Mucosa Correlates With Helicobacter Pylori Infection and Gastric Cancer Occurrence , 2010, Cancer investigation.

[35]  W. Marlicz,et al.  Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole , 2010, European Journal of Clinical Pharmacology.

[36]  T. Tahara,et al.  Influence of MDR1 Polymorphism on H. pylori-Related Chronic Gastritis , 2010, Digestive Diseases and Sciences.

[37]  T. Tahara,et al.  Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis. , 2009, Anticancer research.

[38]  H. Sugimura,et al.  MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese. , 2008, Life sciences.

[39]  T. Tahara,et al.  Multi‐drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population , 2007, Journal of gastroenterology and hepatology.

[40]  Adorjan Aszalos,et al.  Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) II. Clinical aspects. , 2007, Drug discovery today.

[41]  Supratim Choudhuri,et al.  Structure, Function, Expression, Genomic Organization, and Single Nucleotide Polymorphisms of Human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) Efflux Transporters , 2006, International journal of toxicology.

[42]  K. Safranow,et al.  Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection , 2005, European Journal of Clinical Pharmacology.

[43]  R. Laheij,et al.  The importance of corpus biopsies for the determination of Helicobacter pylori infection. , 2005, The Netherlands journal of medicine.